Chongqing Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it will receive CNY 100,000,000 in equity funding on October 25, 2016. The transaction will include participation from returning investor Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. which will maintain its 100% stake in the company after the transaction. The company's registered capital will increase from CNY 34,000,000 to CNY 134,000,000. The transaction has been approved at the 28th session of the 3rd directorate of the investor and is subject to its shareholders’ approval. The company reported total assets of CNY 115,848,609.99, liabilities of CNY 77,690,443.45, net assets of CNY 38,158,166.54, operating revenue of CNY 102,365,006.98, and net loss of CNY 9,533,859.42 for the year ended December 31, 2015.